Clinical Trials in Tennessee

Showing 2061-2080 of 9,675 trials

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

NCT02425566

The purpose of this study is to better understand the role of the abdominal veins (splanchnic capacitance) and the sympathetic nervous system in human hypertension. The investigators will test the hypothesis that constriction of abdominal veins due to sympathetic activation contributes to human hypertension. Splanchnic capacitance will be assessed in normotensive and hypertensive subjects at baseline and during acute blockade of the autonomic nervous system.

Hypertension

Vanderbilt University12 participantsStarted Apr 2015

Nashville, Tennessee, United States

RECRUITINGPhase 229 miles

Tranexamic Acid in Nasal Mohs Reconstruction

NCT06057675

This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.

Postoperative BleedingSkin Cancer Face

Vanderbilt University Medical Center100 participantsStarted Mar 2024

Nashville, Tennessee, United States

COMPLETEDPhase 371 miles

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

NCT04847557

The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejection fraction and obesity.

ObesityHeart Failure With Preserved Ejection Fraction (HFpEF)

Eli Lilly and Company731 participantsStarted Apr 2021

Huntsville, Alabama, United States • Beverly Hills, California, United States • Covina, California, United States +143 more locations

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

Tranexamic Acid in Nasal Mohs Reconstruction

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Find Trials by Condition in Tennessee

Families Left Behind

Virtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among Veterans

PTG-300 in Subjects With Hereditary Hemochromatosis

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer

A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

STICH3C Cardiac Magnetic Resonance Observational Study

The ReTAVI Prospective Observational Registry